NeoStem is focused on developing and building on its core capabilities in cell therapy, to capitalize on the burgeoning cell therapy industry as well as cell therapy’s future role in the fight against chronic disease; the company also desires to aid in lessening the economic burden these diseases pose. NeoStem’s mission is to become a premier cell therapy company. For more information, visit the company’s Web site at www.neostem.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: